Abbott Laboratories announced financial results for the three months ending March 31, 2018. The company reported Net Sales worth Rs. 5.983 billion during the three months against Rs. 5.127 billion same period last year.
Abbott Laboratories reported bottom-line profits worth Rs. 620.232 million with an EPS of 6.34/share.
Unconsolidated Profit and Loss Account – For the Nine Months Ended, March 31, 2018 |
||
---|---|---|
Key Financials |
2018 |
2017 |
Amounts in PKR ‘000 |
||
Net Sales |
5,963,602 |
5,127,078 |
Gross Profit |
2,284,410 |
1,997,040 |
Profit before Taxation |
901,936 |
950,116 |
Profit after Taxation |
620,232 |
704,763 |
EPS – Basic and diluted |
6.34 |
7.20 |
The company release on the financial results can be accessed here.